CD247 p.Arg132His
c.395G>A · rs201594815 · VCV2061545
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3193 | likely benign |
|---|---|---|
| REVEL | 0.197 | benign-leaning |
| SaProt | LLR -10.49 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · C>G here scores Δ0.30 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 5.7 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 0.91 | unconstrained · MANE · 87 kb · p 0.18 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0112% | 8,930 |
| European (non-Finnish)grpmax | 0.0078% | 12,826 |
| African / African-American | 0.00533% | 18,767 |
| Admixed American | 0.005% | 20,010 |
| South Asian | 0.00329% | 30,361 |
| East Asian | 0.00223% | 44,880 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CD247
- Protein
- p.Arg132His
- Coding
- c.395G>A
- MANE Select
- NM_198053
- dbSNP
- rs201594815
- Type
- single nucleotide variant
- Location
- chr1:167433058 (GRCh38)
- Gene constraint
- LOEUF 0.633 · pLI 0.66 (gnomAD)
- Structure
- AlphaFold pLDDT 62.36 · 38 PDB
- Residue 132
- the itam 3 domain; the 'disordered' region
Disease context
immunodeficiency 25 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy
Similar variants
- CD247 p.Arg132Cys Uncertain significance ★★ ⚠ same residue
- CD247 p.Gln101Ter Pathogenic/Likely pathogenic ★★ same condition
- CD247 c.58+6G>T Uncertain significance ★★ same condition
- CD247 p.Ala120Val Uncertain significance ★★ ⚠ same condition
- CD247 p.Ala63Pro Uncertain significance ★★ ⚠ same condition
- CD247 p.Ala9Thr Uncertain significance ★★ ⚠ same condition
- CD247 p.Arg103Lys Uncertain significance ★★ ⚠ same condition
- CD247 p.Arg133Gln Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cd247-p-arg132his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown